1. Home
  2. AXSM
  3. AXSM News

Latest Axsome Therapeutics Inc. (AXSM) News on July 27, 2024

Axsome Therapeutics' CNS Portfolio Poised for Major Growth - Analyst Predicts Strong Future
AXSM

Benzinga

4 days ago

Axsome Therapeutics' CNS Portfolio Poised for Major Growth - Analyst Predicts Strong Future

Bull Market and Beyond: 2 Stocks Just Waiting to Soar
AXSM

Motley Fool

12 days ago

Bull Market and Beyond: 2 Stocks Just Waiting to Soar

Axsome Therapeutics to Report Second Quarter 2024 Financial Results on August 5
AXSM

GlobeNewswire

16 days ago

Axsome Therapeutics to Report Second Quarter 2024 Financial Results on August 5

Investors ignore increasing losses at Axsome Therapeutics (NASDAQ:AXSM) as stock jumps 7.0% this past week
AXSM

Simply Wall St.

a month ago

Investors ignore increasing losses at Axsome Therapeutics (NASDAQ:AXSM) as stock jumps 7.0% this past week

Why Axsome Therapeutics Stock Is Sinking Today
AXSM

Motley Fool

a month ago

Why Axsome Therapeutics Stock Is Sinking Today

Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories
AXSM

GlobeNewswire

2 months ago

Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories

Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During Migraine & Headache Awareness Month
AXSM

GlobeNewswire

2 months ago

Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During Migraine & Headache Awareness Month

Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month
AXSM

GlobeNewswire

2 months ago

Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month

Axsome Therapeutics to Participate in Upcoming Investor Conferences
AXSM

GlobeNewswire

2 months ago

Axsome Therapeutics to Participate in Upcoming Investor Conferences

Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024
AXSM

GlobeNewswire

2 months ago

Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024

Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of Clinical Psychopharmacology Annual (ASCP) Meeting
AXSM

GlobeNewswire

2 months ago

Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of Clinical Psychopharmacology Annual (ASCP) Meeting

3 Monster Stocks in the Making You Can Buy Right Now
AXSM

Motley Fool

2 months ago

3 Monster Stocks in the Making You Can Buy Right Now

15 Most Depressed States in the US
AXSM

Insider Monkey

2 months ago

15 Most Depressed States in the US

Prediction: These 2 Growth Stocks Could Triple By 2030
AXSM

Motley Fool

3 months ago

Prediction: These 2 Growth Stocks Could Triple By 2030

Axsome Therapeutics, Inc. (NASDAQ:AXSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
AXSM

Simply Wall St.

3 months ago

Axsome Therapeutics, Inc. (NASDAQ:AXSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Axsome Therapeutics to Present at Upcoming Investor Conferences
AXSM

GlobeNewswire

3 months ago

Axsome Therapeutics to Present at Upcoming Investor Conferences

Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates
AXSM

Zacks

3 months ago

Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript
AXSM

Insider Monkey

3 months ago

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript

AXSM

GuruFocus.com

3 months ago

Axsome Therapeutics Inc (AXSM) (Q1 2024) Earnings Call Transcript Highlights: Soaring Revenues ...

AXSM

Thomson Reuters StreetEvents

3 months ago

Q1 2024 Axsome Therapeutics Inc Earnings Call

Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript
AXSM

Motley Fool

3 months ago

Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript

Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
AXSM

GlobeNewswire

3 months ago

Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Should You Buy Axsome Therapeutics (AXSM) Ahead of Earnings?
AXSM

Zacks

3 months ago

Should You Buy Axsome Therapeutics (AXSM) Ahead of Earnings?

Axsome Therapeutics Recognizes May as Mental Health Awareness Month
AXSM

GlobeNewswire

3 months ago

Axsome Therapeutics Recognizes May as Mental Health Awareness Month

15 Most Black States in the US
AXSM

Insider Monkey

3 months ago

15 Most Black States in the US

Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting
AXSM

GlobeNewswire

3 months ago

Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting

Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6
AXSM

GlobeNewswire

4 months ago

Axsome Therapeutics to Report First Quarter 2024 Financial Results on May 6

Axsome (AXSM) Begins Solriamfetol Binge Eating Phase III Study
AXSM

Zacks

4 months ago

Axsome (AXSM) Begins Solriamfetol Binge Eating Phase III Study

Insider Sell: COO Mark Jacobson Sells 24,662 Shares of Axsome Therapeutics Inc (AXSM)
AXSM

GuruFocus.com

4 months ago

Insider Sell: COO Mark Jacobson Sells 24,662 Shares of Axsome Therapeutics Inc (AXSM)

Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder
AXSM

GlobeNewswire

4 months ago

Axsome Therapeutics Initiates ENGAGE Phase 3 Trial of Solriamfetol for the Treatment of Binge Eating Disorder

30 Countries with the Lowest Depression Rates
AXSM

Insider Monkey

4 months ago

30 Countries with the Lowest Depression Rates

20 Cloudiest Cities in the U.S., Ranked
AXSM

Insider Monkey

4 months ago

20 Cloudiest Cities in the U.S., Ranked

Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients
AXSM

GlobeNewswire

4 months ago

Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy
AXSM

GlobeNewswire

4 months ago

Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy

Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
AXSM

Motley Fool

4 months ago

Buying These Dirt-Cheap Stocks Could Be a Brilliant Move

Axsome Triumphs Over Major Depressive Disorder With Auvelity
AXSM

GuruFocus.com

4 months ago

Axsome Triumphs Over Major Depressive Disorder With Auvelity

Axsome (AXSM) Begins Dosing in Depression Study on Sunosi
AXSM

Zacks

4 months ago

Axsome (AXSM) Begins Dosing in Depression Study on Sunosi

Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive Disorder
AXSM

GlobeNewswire

4 months ago

Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive Disorder

11 Oversold NASDAQ Stocks To Buy Right Now
AXSM

Insider Monkey

4 months ago

11 Oversold NASDAQ Stocks To Buy Right Now

Axsome Therapeutics to Present at the Leerink Partners Global Biopharma Conference
AXSM

GlobeNewswire

5 months ago

Axsome Therapeutics to Present at the Leerink Partners Global Biopharma Conference

Axsome Therapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
AXSM

GlobeNewswire

5 months ago

Axsome Therapeutics to Present at the TD Cowen 44th Annual Healthcare Conference

3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024
AXSM

InvestorPlace

5 months ago

3 Under-the-Radar Biotech Stocks With Upcoming Catalysts in 2024

3 Biotech Stocks to Buy and Hold for the Next 10 Years
AXSM

Motley Fool

5 months ago

3 Biotech Stocks to Buy and Hold for the Next 10 Years

Axsome (AXSM) Stock Falls Despite Q4 Earnings & Revenue Beat
AXSM

Zacks

5 months ago

Axsome (AXSM) Stock Falls Despite Q4 Earnings & Revenue Beat

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2023 Earnings Call Transcript
AXSM

Insider Monkey

5 months ago

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q4 2023 Earnings Call Transcript

AXSM

Thomson Reuters StreetEvents

5 months ago

Q4 2023 Axsome Therapeutics Inc Earnings Call

Axsome Therapeutics Inc (AXSM) Reports Robust Revenue Growth in Q4 and Full Year 2023
AXSM

GuruFocus.com

5 months ago

Axsome Therapeutics Inc (AXSM) Reports Robust Revenue Growth in Q4 and Full Year 2023

Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
AXSM

GlobeNewswire

5 months ago

Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Axsome Therapeutics (AXSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
AXSM

Zacks

5 months ago

Axsome Therapeutics (AXSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Breakeven On The Horizon For Axsome Therapeutics, Inc. (NASDAQ:AXSM)
AXSM

Simply Wall St.

5 months ago

Breakeven On The Horizon For Axsome Therapeutics, Inc. (NASDAQ:AXSM)

2 Stocks That Could Double Your Money in 5 Years
AXSM

Motley Fool

6 months ago

2 Stocks That Could Double Your Money in 5 Years

Wayfair (NYSE:W) dips 10% this week as increasing losses might not be inspiring confidence among its investors
AXSM

Simply Wall St.

6 months ago

Wayfair (NYSE:W) dips 10% this week as increasing losses might not be inspiring confidence among its investors

AutoNation Announces Fourth Quarter 2023 Earnings Conference Call and Audio Webcast Scheduled for Tuesday, February 13, 2024
AXSM

PR Newswire

6 months ago

AutoNation Announces Fourth Quarter 2023 Earnings Conference Call and Audio Webcast Scheduled for Tuesday, February 13, 2024

A Motley Fool Co-Founder's Roller-Coaster Nvidia Story
AXSM

Motley Fool

6 months ago

A Motley Fool Co-Founder's Roller-Coaster Nvidia Story

AXSM

GlobeNewswire

6 months ago

Simplicity Group Unveils WeDYOR: Transforming Due Diligence for Crypto Investments

Automotive Telematics Market to Exceed USD 34.52 billion by 2031 | According to Transparency Market Research Analysis
AXSM

GlobeNewswire

6 months ago

Automotive Telematics Market to Exceed USD 34.52 billion by 2031 | According to Transparency Market Research Analysis

AXSM

Business Wire

6 months ago

Form 8.3 - DX (Group) plc

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research
AXSM

GlobeNewswire

6 months ago

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30
AXSM

CNW Group

6 months ago

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

Africa Smart Manufacturing Market Sees Upsurge: Comprehensive Analysis and Growth Forecasts Up to 2030
AXSM

GlobeNewswire

6 months ago

Africa Smart Manufacturing Market Sees Upsurge: Comprehensive Analysis and Growth Forecasts Up to 2030

United Arab Emirates Smart Manufacturing Market Analysis Showcases Growth Trends and Opportunities up to 2030
AXSM

GlobeNewswire

6 months ago

United Arab Emirates Smart Manufacturing Market Analysis Showcases Growth Trends and Opportunities up to 2030

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit
AXSM

Barrons.com

6 months ago

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit

Phenomenex Launches PhenoAcademy for Cutting-Edge Chromatography Education
AXSM

PR Newswire

6 months ago

Phenomenex Launches PhenoAcademy for Cutting-Edge Chromatography Education

CNA Financial (CNA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
AXSM

Zacks

6 months ago

CNA Financial (CNA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Big Tech earnings: What markets are expecting this week
AXSM

Yahoo Finance Video

6 months ago

Big Tech earnings: What markets are expecting this week

Murphy Oil Corporation (NYSE:MUR) Q4 2023 Earnings Call Transcript
AXSM

Insider Monkey

6 months ago

Murphy Oil Corporation (NYSE:MUR) Q4 2023 Earnings Call Transcript

Baillie Gifford Trims Stake in Samsara Inc
AXSM

GuruFocus.com

6 months ago

Baillie Gifford Trims Stake in Samsara Inc

5 Top Growth Stocks to Buy as Recession Fears Subside
AXSM

Zacks

6 months ago

5 Top Growth Stocks to Buy as Recession Fears Subside

Murphy Oil Full Year 2023 Earnings: EPS Misses Expectations
AXSM

Simply Wall St.

6 months ago

Murphy Oil Full Year 2023 Earnings: EPS Misses Expectations

Director Tim Bentsen Sells 4,671 Shares of Synovus Financial Corp (SNV)
AXSM

GuruFocus.com

6 months ago

Director Tim Bentsen Sells 4,671 Shares of Synovus Financial Corp (SNV)

Here's How Clorox (CLX) is Placed Just Ahead of Q2 Earnings
AXSM

Zacks

6 months ago

Here's How Clorox (CLX) is Placed Just Ahead of Q2 Earnings

ADT Provides Solar Business Update and Advances Capital Allocation Strategy
AXSM

GlobeNewswire

6 months ago

ADT Provides Solar Business Update and Advances Capital Allocation Strategy

Venmo and other payment app theft is ‘skyrocketing,’ Manhattan DA warns
AXSM

CNN Business

6 months ago

Venmo and other payment app theft is ‘skyrocketing,’ Manhattan DA warns

Axsome Therapeutics Stock Showing Leadership, Earns 91 RS Rating
AXSM

Investor's Business Daily

6 months ago

Axsome Therapeutics Stock Showing Leadership, Earns 91 RS Rating

Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts
AXSM

Business Wire

6 months ago

Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts

Axsome Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20
AXSM

GlobeNewswire

6 months ago

Axsome Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20

My 3 Favorite Stocks to Buy Right Now
AXSM

Motley Fool

6 months ago

My 3 Favorite Stocks to Buy Right Now

Here's Why You Should Retain Chemed (CHE) Stock for Now
AXSM

Zacks

6 months ago

Here's Why You Should Retain Chemed (CHE) Stock for Now

3 Top-Rated Russell 2000 Stocks Wall Street Analysts Are Loving Now: January 2024
AXSM

InvestorPlace

6 months ago

3 Top-Rated Russell 2000 Stocks Wall Street Analysts Are Loving Now: January 2024

Quest Diagnostics (DGX) and Fitbit Team Up for New Pilot Study
AXSM

Zacks

6 months ago

Quest Diagnostics (DGX) and Fitbit Team Up for New Pilot Study

RBC Bearings (RBC) Gains 17.2% in a Year: Will the Trend Last?
AXSM

Zacks

6 months ago

RBC Bearings (RBC) Gains 17.2% in a Year: Will the Trend Last?

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
AXSM

Zacks

6 months ago

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Here's Why You Should Retain Glaukos (GKOS) Stock for Now
AXSM

Zacks

6 months ago

Here's Why You Should Retain Glaukos (GKOS) Stock for Now

ADT (NYSE:ADT shareholders incur further losses as stock declines 3.2% this week, taking one-year losses to 34%
AXSM

Simply Wall St.

6 months ago

ADT (NYSE:ADT shareholders incur further losses as stock declines 3.2% this week, taking one-year losses to 34%

18 Most Profitable Value Stocks Now
AXSM

Insider Monkey

6 months ago

18 Most Profitable Value Stocks Now

Hertz’s Retreat from EVs Looks Bearish for Tesla. How Avis Avoided the Mess.
AXSM

Barrons.com

6 months ago

Hertz’s Retreat from EVs Looks Bearish for Tesla. How Avis Avoided the Mess.

Glaukos' (GKOS) Preliminary Q4 Revenues Ride on Product Demand
AXSM

Zacks

6 months ago

Glaukos' (GKOS) Preliminary Q4 Revenues Ride on Product Demand

This IBD 50 Travel Stock Bounces At Exactly The Right Place
AXSM

Investor's Business Daily

7 months ago

This IBD 50 Travel Stock Bounces At Exactly The Right Place

Axsome (AXSM) Stock Rises on Stellar Q4 Preliminary Results
AXSM

Zacks

7 months ago

Axsome (AXSM) Stock Rises on Stellar Q4 Preliminary Results

Boyd Gaming to Report Fourth-Quarter, Full-Year 2023 Results, Host Conference Call and Webcast on February 8
AXSM

Business Wire

7 months ago

Boyd Gaming to Report Fourth-Quarter, Full-Year 2023 Results, Host Conference Call and Webcast on February 8

Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2023 Net Revenue and 2024 Anticipated Milestones
AXSM

GlobeNewswire

7 months ago

Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2023 Net Revenue and 2024 Anticipated Milestones

3 Stocks That Have Turned $50,000 Into More Than $500,000 in Just 5 Years
AXSM

Motley Fool

7 months ago

3 Stocks That Have Turned $50,000 Into More Than $500,000 in Just 5 Years

AI: Legal challenges that pose a risk to AI in 2024
AXSM

Yahoo Finance Video

7 months ago

AI: Legal challenges that pose a risk to AI in 2024

2 Biotech Stocks You Can Buy and Hold for the Next Decade
AXSM

Motley Fool

7 months ago

2 Biotech Stocks You Can Buy and Hold for the Next Decade

Investing in Axsome Therapeutics (NASDAQ:AXSM) five years ago would have delivered you a 796% gain
AXSM

Simply Wall St.

7 months ago

Investing in Axsome Therapeutics (NASDAQ:AXSM) five years ago would have delivered you a 796% gain

There's Been No Shortage Of Growth Recently For FTAI Aviation's (NASDAQ:FTAI) Returns On Capital
AXSM

Simply Wall St.

7 months ago

There's Been No Shortage Of Growth Recently For FTAI Aviation's (NASDAQ:FTAI) Returns On Capital

Prediction: These 3 Stocks Will Soar in 2024
AXSM

Motley Fool

7 months ago

Prediction: These 3 Stocks Will Soar in 2024

Returns On Capital Are Showing Encouraging Signs At Boyd Gaming (NYSE:BYD)
AXSM

Simply Wall St.

7 months ago

Returns On Capital Are Showing Encouraging Signs At Boyd Gaming (NYSE:BYD)

15 Best Franchises To Own in 2024
AXSM

Insider Monkey

7 months ago

15 Best Franchises To Own in 2024

Here's Why We Think Timken (NYSE:TKR) Might Deserve Your Attention Today
AXSM

Simply Wall St.

7 months ago

Here's Why We Think Timken (NYSE:TKR) Might Deserve Your Attention Today

Share on Social Networks: